Skip to content

Royan Institute

  Home arrow News arrow Royan News arrow 10th Royan International Summer School
PDF Print E-mail

10th Royan International Summer School

The 10th Royan International Summer School on Molecular Biomedicine from Diagnostics to Therapeutics was held on July 13th to 17th, 2019 at Royan Institute.
More than 300 undergraduate, graduate and postgraduate students got the chance to taste different aspects of the rapidly growing, multidisciplinary field of Molecular Biomedicine from Diagnostics to Therapeutics in order to gain invaluable insights towards finding their area of interest for their future research in the field.

The school was deliberately designed to cover a broad range of topics as follow:

  • Gene and Molecular Therapy Approaches for Treating “Epidermolysis Bullosa”
  • The Potential of MicroRNAs for Targeting Treatment-Resistant Leukemic Stem Cells
  • Glucose-Responsive Skin Patch for Diabetes Treatment
  • Sensors, Biosensors, and Nanosensor
  • Clinical Use of Tumor Biomarkers in Diagnosis and Prognosis of Cancers
  • Enlightened Tomorrow of Biomolecular Diagnostics by Clark's Legacy: Biosensingand Transduction
  • Contribution of Molecular Diagnosis and Therapy to Future Medicine
  • Application of Gene Editing in Generating Genetically Modified Animal Models
  • Genome Editing and CAR-T Cell Technology
  • Engineering Approaches to the Selection of Effective Cancer Drugs
  • Anti-Cancer Drug Delivery Systems
  • Development of Therapeutic Cancer Vaccines
  • Regulation of the Tumor Microenvironment by Exosome-Shuttled MicroRNAs
  • Biosensors: from Designing to Manufacturing
  • The Potential of Extracellular Vesicles as Disease Biomarkers
  • SOP Preparation to Evaluate Tumor Biomarkers
  • Nanotechnology in Cancer Diagnosis
  • Gene Therapy and Gene Editing for Treating Haemoglobinopathies
  • How to Commercialize Your Product: Marketing of Therapeutic Products
  • RNAiTherapeutics

This program was organized by Dr Sh Moradi as scientific Manager and M Najar Asl as the executive secretary and their colleagues in Royan Institute for Stem Cell Biology and Technology.

Main Menu